3/14
Health Sciences
Older adults might be more resistant to bird flu infections than children
New research from Penn Medicine finds that previous exposures to older flu strains prime the immune system to produce antibodies against H5N1, and children would likely benefit the most from H5N1 vaccinations.
Survey shows patients with disabilities less likely to feel respect from doctors
A new Penn Medicine analysis shows that patients with disabilities were both less likely to feel respect from their doctors and less likely to feel their doctors explained things well.
Innate immune training aggravates inflammatory bone loss
Researchers from the School of Dental Medicine and international collaborators from Germany have investigated the effects of training the innate immune system in experimental models of chronic inflammatory disease, periodontitis and arthritis.
Exploring the role of AI in palliative care and decision-making
Working with professors George Demiris and Connie Ulrich, Penn Nursing Ph.D. student Oonjee Oh is investigating the role of AI in end-of-life care from technological and ethical perspectives.
One tiny dog’s outsized contribution to brain surgery
A terrier mix makes history as the first patient to undergo canine neurosurgery in a collaborative effort of specialists in human and veterinary medicine using cutting-edge augmented reality technology and infrared imaging.
Text message tool addresses ‘time toxicity’ for cancer patients
In pilot study from Penn Medicine, patients saved over an hour of time at every treatment visit using digital technology.
New mRNA therapy could repair damaged lungs
Penn researchers have designed an organ-specific mRNA and lipid nanoparticle therapy which could lead to new targeted treatments for damaged organs.
Getting to the root of root canals
Penn researchers use iron oxide nanozymes to treat infections during root canals with fewer adverse effects than clinical gold standard while also promoting tissue healing.
Increased cancer risk for kidney transplant recipients linked to Epstein-Barr virus
Researchers suggest changes in kidney transplant care and monitoring.
With hemophilia B, a lifetime of worry eased with one infusion
The first Penn Medicine patient to receive an FDA-approved new gene therapy for hemophilia B can now stop regular prophylactic clotting factor injections.
In the News
Why researchers are sure that the COVID vaccine saved millions of lives
According to a 2024 survey by the Annenberg Public Policy Center, a growing number of Americans mistakenly believe that COVID vaccines have been responsible for thousands of deaths.
FULL STORY →
Measles is unlike other viruses: What to know about long-term complications
E. John Wherry of the Perelman School of Medicine says that relearning viral immunity can lead people to be especially prone to other infections right after measles.
FULL STORY →
Children, teens face 25% higher risk for adverse GI outcomes after COVID-19 infection
According to a study by Ph.D. student Dazheng Zhang of the Perelman School of Medicine and colleagues, children and adolescents experienced increased risk for gastrointestinal symptoms and disorders after COVID-19 infections.
FULL STORY →
Pennsylvania doctors reflect on COVID-19 pandemic 5 years later
Raina Merchant of the Perelman School of Medicine says that Penn Medicine had to be nimble during the COVID-19 pandemic to respond to many changes in information and optimize care for patients.
FULL STORY →
Is This Viral Trend Really the Ultimate Cure for Bloat?
Anish A. Sheth of the Perelman School of Medicine says there’s no medical evidence that topical castor oil has any medically therapeutic benefits.
FULL STORY →